JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirsch, A. J.
Right arrow Articles by Nelson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirsch, A. J.
Right arrow Articles by Nelson, J. A.
Journal of Virology, September 2005, p. 11943-11951, Vol. 79, No. 18
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.18.11943-11951.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

The Src Family Kinase c-Yes Is Required for Maturation of West Nile Virus Particles

Alec J. Hirsch,1* Guruprasad R. Medigeshi,1 Heather L. Meyers,1 Victor DeFilippis,1 Klaus Früh,1 Thomas Briese,2 W. Ian Lipkin,2 and Jay A. Nelson1*

Vaccine and Gene Therapy Institute, Oregon Health & Sciences University, 505 N.W. 185th Avenue, Beaverton, Oregon 97006,1 Jerome L. and Dawn Greene Infectious Disease Laboratory, Mailman School of Public Health of Columbia University, 722 W 168th Street, 18th Floor, New York, New York 100322

Received 18 April 2005/ Accepted 17 June 2005

The role of cellular genes in West Nile virus (WNV) replication is not well understood. Examination of cellular transcripts upregulated during WNV infection revealed an increase in the expression of the src family kinase (SFK) c-Yes. WNV-infected cell lines treated with the SFK inhibitor PP2 demonstrated a 2- to 4-log decrease in viral titers, suggesting that SFK activity is required for completion of the viral replication cycle. RNA interference mediated knock-down of c-Yes, but not c-Src, and similarly reduced virus yield, specifically implicating c-Yes in WNV production. Interestingly, PP2 treatment did not reduce intracellular levels of either viral RNA or protein, suggesting that the drug does not act on the early stages of replication. However, endoglycosidase H (endoH) digestion of the viral envelope (E) glycoprotein revealed that the acquisition of endoH-resistant glycans by E, but not endogenous major histocompatibility complex class I, was reduced in PP2-treated cells, demonstrating that E specifically does not traffic beyond the endoplasmic reticulum in the absence of SFK activity. Electron microscopy further revealed that PP2-treated WNV-infected cells accumulated an increased number of virions in the ER compared to untreated cells. Therefore, we conclude that inhibition of SFK activity did not interfere with virus assembly but prevented transit of virions through the secretory pathway. These results identify c-Yes as a cellular protein that is involved in WNV assembly and egress.


* Corresponding author. Mailing address: Vaccine and Gene Therapy Institute, Oregon Health & Sciences University, 505 N.W. 185th Avenue, Beaverton, Oregon 97006. Phone: (503) 418-2710. Fax: (503) 418-2701. E-mail for A. J. Hirsch: hirschal{at}ohsu.edu. E-mail for J. A. Nelson: nelsonj{at}ohsu.edu.


Journal of Virology, September 2005, p. 11943-11951, Vol. 79, No. 18
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.18.11943-11951.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.